powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1013402759
Sharini Venugopal
MD
Endocrinology
California,
MD
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 090011
Hospital
CCN 210028
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,319
Beneficiaries
—
Total drug cost
$869K
Distinct drugs
24
Brand share
68.8%
Top prescribed drugs
Tirzepatide
178 claims
Semaglutide
145 claims
Empagliflozin
75 claims
Metformin Hcl
75 claims
Insulin Glargine,hum.Rec.Anlog
74 claims
QUALITY · MIPS · 2024
Final MIPS score
81.4
Quality
61.5
Cost
79.9
Improvement activities
40.0
Promoting interop.
96.0
Payment adjustment
0.27%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,265
Unique beneficiaries
—
Total services
1,826
Distinct HCPCS
17
Medicare payment
$85K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 170 Endocrinology providers in MD — above median (cohort median 1,214).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$674
Payment records
26
By payment type
Food and Beverage
$674
Top paying entities
Food and Beverage
$674
